JPMorgan Chase & Co’s Immunome IMNM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.36M | Sell |
576,130
-43,408
| -7% | -$404K | ﹤0.01% | 2652 |
|
|
2025
Q1 | $4.17M | Sell |
619,538
-29,072
| -4% | -$196K | ﹤0.01% | 2791 |
|
|
2024
Q4 | $6.89M | Buy |
648,610
+624,045
| +2,540% | +$6.63M | ﹤0.01% | 2523 |
|
|
2024
Q3 | $359K | Buy |
24,565
+1,520
| +7% | +$22.2K | ﹤0.01% | 4198 |
|
|
2024
Q2 | $279K | Buy |
23,045
+22,317
| +3,066% | +$270K | ﹤0.01% | 4105 |
|
|
2024
Q1 | $18K | Sell |
728
-17,574
| -96% | -$434K | ﹤0.01% | 5257 |
|
|
2023
Q4 | $196K | Buy |
+18,302
| New | +$196K | ﹤0.01% | 4454 |
|
|
2023
Q3 | – | Sell |
-915
| Closed | -$7.24K | – | 6570 |
|
|
2023
Q2 | $7.24K | Buy |
+915
| New | +$7.24K | ﹤0.01% | 5218 |
|
|
2021
Q3 | – | Sell |
-768
| Closed | -$13K | – | 5636 |
|
|
2021
Q2 | $13K | Sell |
768
-5,089
| -87% | -$86.1K | ﹤0.01% | 5179 |
|
|
2021
Q1 | $198K | Buy |
5,857
+126
| +2% | +$4.26K | ﹤0.01% | 4456 |
|
|
2020
Q4 | $55K | Buy |
+5,731
| New | +$55K | ﹤0.01% | 4427 |
|